These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25193162)

  • 1. Development of a new clot formation protocol for standardized in vitro investigations of sonothrombolysis.
    Roessler FC; Teichert A; Ohlrich M; Marxsen JH; Stellmacher F; Tanislav C; Seidel G
    J Neurosci Methods; 2014 Nov; 237():26-32. PubMed ID: 25193162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The platelet-rich plasma clot: a standardized in-vitro clot formation protocol for investigations of sonothrombolysis under physiological flows.
    Roessler FC; Ohlrich M; Marxsen JH; Stellmacher F; Sprenger A; Dempfle CE; Seidel G
    Blood Coagul Fibrinolysis; 2011 Jul; 22(5):407-15. PubMed ID: 21519235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonothrombolysis is effective with recombinant tissue-type plasminogen activator, but not with Abciximab. Results from an in vitro study with whole blood clots and platelet-rich clots.
    Eggers J; Ossadnik S; Hütten H; Seidel G
    Thromb Haemost; 2009 Dec; 102(6):1274-7. PubMed ID: 19967161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Examination of the Thrombolytic Efficacy of Desmoteplase and Therapeutic Ultrasound Compared with rt-PA.
    Roessler FC; Wang Z; Schumacher S; Ohlrich M; Kaps M; Menciassi A; Eggers J
    Ultrasound Med Biol; 2015 Dec; 41(12):3233-40. PubMed ID: 26349583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
    Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I
    Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
    Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with rt-PA is more effective than rt-PA alone in an in vitro human clot model.
    Meunier JM; Holland CK; Porter TM; Lindsell CJ; Shaw GJ
    Curr Neurovasc Res; 2011 Nov; 8(4):305-12. PubMed ID: 22023612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA).
    Trusen B; Ries M; Zenker M; Rauh M; Beinder E; Keuper H; Harms D
    Semin Thromb Hemost; 1998; 24(6):599-604. PubMed ID: 10066156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound affects distribution of plasminogen and tissue-type plasminogen activator in whole blood clots in vitro.
    Devcic-Kuhar B; Pfaffenberger S; Gherardini L; Mayer C; Gröschl M; Kaun C; Benes E; Tschachler E; Huber K; Maurer G; Wojta J; Gottsauner-Wolf M
    Thromb Haemost; 2004 Nov; 92(5):980-5. PubMed ID: 15543323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.
    Parise P; Morini M; Agnelli G; Ascani A; Nenci GG
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):721-7. PubMed ID: 8292721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
    van Giezen JJ; Boon GI; Jansen JW; Bouma BN
    Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
    Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
    Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term high-dose effect of lovastatin on thrombolysis by rt-PA in a human whole-blood in vitro clot model.
    Kandadai MA; Meunier J; Lindsell CJ; Shaw GJ; Elkind MS
    Curr Neurovasc Res; 2012 Aug; 9(3):207-13. PubMed ID: 22621227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual lytic efficacy of recombinant tissue plasminogen activator in an in vitro human clot model: rate of "nonresponse".
    Meunier JM; Wenker E; Lindsell CJ; Shaw GJ
    Acad Emerg Med; 2013 May; 20(5):449-55. PubMed ID: 23672358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of clot aging and cholesterol content on ultrasound-assisted thrombolysis.
    Zhou Y; Murugappan SK; Sharma VK
    Transl Stroke Res; 2014 Oct; 5(5):627-34. PubMed ID: 24488442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
    Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M; Lijnen HR; Keber D; Collen D
    Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clot Formation in the Presence of Acetylsalicylic Acid Leads to Increased Lysis Rates Regardless of the Chosen Thrombolysis Strategy.
    Roessler FC; Schumacher S; Sprenger A; Gärtner U; Al-Khaled M; Eggers J
    J Vasc Res; 2016; 53(3-4):128-137. PubMed ID: 27710967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin(ogen)olytic character of FIIa isolated from Agkistrodon acutus venom.
    Wang YW; Liang XX; Chen JS; Chen Q; Qiu PX; Lin X; Yan GM
    Acta Pharmacol Sin; 2005 Jun; 26(6):691-5. PubMed ID: 15916735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.